OpenAI is officially going global, and it’s starting in London. The company announced its first international expansion on Wednesday, establishing a new office in the UK capital. This isn’t just a satellite sales team; the plan is to put down serious R&D roots in a city Sam Altman clearly sees as a peer to the Bay Area, not a backwater. The move signals that the race for AI talent is now a fully global affair, and OpenAI intends to hunt on multiple continents.
Diane Yoon, OpenAI’s VP of People, framed the expansion around access to a “globally renowned” talent pool, specifically calling out the need to build “dynamic teams” in research, engineering, and go-to-market functions. The message is clear: they’re not just hiring a few account managers. They are shipping core research capabilities across the Atlantic. For a company whose entire identity is built on the scarcity of top-tier AI researchers, planting a flag in a hub like London—with its concentration of DeepMind alumni and university labs—is a direct competitive jab. It’s a practical acknowledgment that not every brilliant mind wants to relocate to San Francisco.
The London office is officially tasked with a dual mandate: advancing research and engineering while also collaborating with local policymakers. That latter point is crucial. As the EU finalizes its AI Act and the UK charts its own post-Brexit regulatory path, having a physical presence for policy work is no longer optional. Altman’s statement specifically linked the expansion to driving innovation in “AGI development and policy,” underscoring that the two are now intertwined. You can’t safely deploy the technology they’re building without a seat at the regulatory table, and a London office provides exactly that.
The big question is scale. OpenAI’s announcement is light on specifics—no headcount targets, no named research leads, and no shiny new Kings Cross office address just yet. For now, it’s a signal of intent backed by a careers page. The real verdict on whether this is a transformative lab or just a prestigious outpost will come when we see who they hire. If they start poaching senior research scientists from the local heavyweights, it’s a game on. If not, it’s a very expensive real estate play for regulatory affairs.
